HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$9.13
Day range
$9.15 - $9.64
Year range
$4.20 - $9.64
Market cap
511.61M USD
Avg Volume
626.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.70M | 27.63% |
Operating expense | 28.70M | 58.42% |
Net income | -33.22M | -220.49% |
Net profit margin | -899.19 | -151.10% |
Earnings per share | -0.69 | -72.50% |
EBITDA | -25.69M | -67.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 89.38M | 7.13% |
Total assets | 191.55M | 37.82% |
Total liabilities | 121.78M | 70.29% |
Total equity | 69.77M | — |
Shares outstanding | 53.38M | — |
Price to book | 6.97 | — |
Return on assets | -40.64% | — |
Return on capital | -61.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -33.22M | -220.49% |
Cash from operations | -18.14M | -291.98% |
Cash from investing | -31.35M | 29.47% |
Cash from financing | 64.76M | 146.64% |
Net change in cash | 14.78M | 164.46% |
Free cash flow | -5.10M | 88.02% |
About
Founded
2006
Website
Employees
67
